Daniel Westaby

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth”.

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth

Research Square(2022)10.21203/rs.3.rs-2092111/v1

N/A

0DataRank · unranked

1 citations

Emma Scott, Kirsty Hodgson, Beatriz de la Calle, Helen Turner, Kathleen Cheung +54 more

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth

Oncogene(2023)10.1038/s41388-023-02604-x

N/A

0DataRank · unranked

74 citations

Kirsty Hodgson, Beatriz de la Calle, Helen Turner, Kathleen Cheung, Abel Bermudez +54 more

BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress

Nature Communications(2025)10.1038/s41467-025-60238-x

N/A

0DataRank · unranked

11 citations

Keshan Wang, Mannan Nouri, N. V. Kozlova, Daniel R. Schmidt, Anastasia Stavridi +27 more

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

Nature Communications(2025)10.1038/s41467-025-64042-5

N/A

0DataRank · unranked

6 citations

Daniel Westaby, Ines Figueiredo, Alexis de Haven Brandon, Ana Padilha, Wei Yuan +53 more

Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer

iScience(2025)10.1016/j.isci.2025.113985

N/A

0DataRank · unranked

1 citations

Juan M. Jiménez-Vacas, Ines Figueiredo, Jonathan Welti, Bora Gurel, Denisa Bogdan +22 more